Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 607917 | ISIN: US01988P1084 | Ticker-Symbol: AL21
Stuttgart
21.11.24
08:03 Uhr
9,300 Euro
+0,100
+1,09 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
VERADIGM INC Chart 1 Jahr
5-Tage-Chart
VERADIGM INC 5-Tage-Chart
RealtimeGeldBriefZeit
7,0007,70017:12

Aktuelle News zur VERADIGM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13.11.Veradigm Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB-
10.11.McKesson, Oracle, Thoma Bravo among finalists to acquire Veradigm: report5
VERADIGM Aktie jetzt für 0€ handeln
08.10.Veradigm (NASDAQ:MDRX) Shares Gap Down - What's Next?3
03.10.Veradigm says Veradigm eChart Courier expands to 300,000 healthcare providers2
03.09.Veradigm Inc. ends credit facility to avoid default1
03.09.Veradigm Inc. - 8-K, Current Report2
13.08.Veradigm reports strong cash position, reduced debt8
12.08.Veradigm Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB1
12.08.Veradigm Inc. - 8-K, Current Report1
12.08.Veradigm gains after report of bids in sales process1
29.07.Veradigm Inc. - 8-K, Current Report1
28.05.Veradigm names new interim CEO, reaffirms guidance, explores strategic alternatives1
28.05.Veradigm Inc. - 8-K, Current Report1
10.05.Black Book Market Research: Veradigm Payerpath Rated Highest in Client Satisfaction for Small Physician Practice Clearinghouse Services, 2024 Black Book Survey291TAMPA, FL / ACCESSWIRE / May 10, 2024 / Black Book Research's annual poll of over 13,000 medical practice IT users grading customer experience of contracted enterprise clearinghouses revealed that Veradigm...
► Artikel lesen
25.04.Delisting of Securities of Northern Revival Acquisition Corporation; Veradigm Inc.; Neptune Wellness Solutions Inc.; Panbela Therapeutics, Inc.; Bit Brother Limited; Nocturne Acquisition Corporation; View, Inc. and others from The Nasdaq Stock Market531NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the ordinary shares, unit, and warrants of Northern Revival Acquisition Corporation. Northern...
► Artikel lesen
08.03.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 08.03.2024543The following instruments on Boerse Frankfurt do have their last trading day on 08.03.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 08.03.2024.ISIN NameCA51830A1066 LATITUDE...
► Artikel lesen
04.03.Veradigm Completes Acquisition of ScienceIO183 CHICAGO--(BUSINESS WIRE)--Veradigm Inc. (OTCMKTS: MDRX) (the "Company"), a leading provider of healthcare data and technology products and solutions, today announced that it has completed its acquisition...
► Artikel lesen
28.02.Veradigm Receives Expected Delisting Notice from Nasdaq187CHICAGO--(BUSINESS WIRE)--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products and solutions, announced today that, as expected, it received a notice from...
► Artikel lesen
27.02.Veradigm Provides Update on its Financial Restatement Process182CHICAGO--(BUSINESS WIRE)--Veradigm Inc. (NASDAQ: MDRX) (the "Company"), a leading provider of healthcare data and technology products and solutions, announced today that the Company does not expect...
► Artikel lesen
27.02.Veradigm to Acquire ScienceIO245CHICAGO--(BUSINESS WIRE)--Veradigm Inc. (NASDAQ: MDRX) (the "Company"), a leading provider of healthcare data and technology products and solutions, today announced that it has signed a definitive...
► Artikel lesen
Seite:  Weiter >>
22 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1